Positron Emission Tomography (PET) Predictors of Tumor Response to Peptide Receptor Radionuclide Therapy (PRRT) in Metastatic Neuroendocrine Tumors (NET)

被引：0
|
作者：
Ladwa, R. [1 ]
Pattison, D. [2 ]
Smith, J. [2 ]
Goodman, S. [2 ]
Burge, M. [3 ]
Rose, S. [4 ]
Dowson, N. [4 ]
Wyld, D. [3 ]
机构：
[1] Univ Queensland, Sch Med, Princess Alexandra Hosp, Dept Med Oncol, Brisbane, Qld, Australia
[2] Royal Brisbane & Womens Hosp, Nucl Med & Specialised PET Serv, Brisbane, Qld, Australia
[3] Univ Queensland, Royal Brisbane & Womens Hosp, Sch Med, Canc Care Serv, Brisbane, Qld, Australia
[4] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Brisbane, Qld, Australia
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
68ga-dotatate pet-ct; suv parameters; tumor response; somatostatin receptor tumor volume;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
K11
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [1] Evaluation of toxicity in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NET)
    Duan, H.
    Ferri, V.
    Kunz, P. L.
    Fisher, G. A.
    Moradi, F.
    Davidzon, G. A.
    Franc, B. L.
    Iagaru, A. H.
    Mari, C. Aparici
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S471 - S472
  • [2] Evaluation of Toxicity in Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumors (NET)
    Duan, H.
    Girod, B.
    Ninatti, G.
    Ferri, V
    Kunz, P.
    Fisher, G.
    Moradi, F.
    Davidzon, G.
    Franc, B.
    Lagaru, A.
    Aparici, Mari C.
    NEUROENDOCRINOLOGY, 2020, 110 : 252 - 252
  • [3] Single Institution Experience with Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
    Duan, H.
    Ninatti, G.
    Girod, B.
    Ferri, V
    Guja, K.
    Song, H.
    Kunz, P.
    Fisher, G.
    Lagaru, A.
    Mari, Aparici C.
    NEUROENDOCRINOLOGY, 2020, 110 : 253 - 253
  • [4] Single institution experience with peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET)
    Duan, Heying
    Ninatti, Gaia
    Girod, Bradley
    Ferri, Valentina
    Kunz, Pamela L.
    Fisher, George A.
    Moradi, Farshad
    Davidzon, Guido Alejandro
    Franc, Benjamin Lewis
    Iagaru, Andrei
    Mari, Carina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [5] Single Institution Experience With Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
    Duan, H.
    Ferri, V.
    Kunz, P.
    Davidzon, G.
    Nguyen, J.
    Moradi, F.
    Franc, B.
    Iagaru, A.
    Aparici, C. Mari
    PANCREAS, 2021, 50 (03) : 456 - 456
  • [6] Peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NET): A single institution experience in the USA
    Duan, H.
    Ferri, V.
    Kunz, P. L.
    Fisher, G. A.
    Moradi, F.
    Davidzon, G. A.
    Franc, B. L.
    Iagaru, A. H.
    Mari, C. Aparici
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S468 - S469
  • [7] Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Metastatic Neuroendocrine Tumors: How Effective and Safe Are They?
    Liotsou, T.
    Stefanoyiannis, A. P.
    Chatziioannou, S. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S725 - S726
  • [8] Outcomes of peptide receptor radionuclide therapy (PRRT) in metastatic grade 3 neuroendocrine tumors (NETs).
    Lung, Mei Sim
    Hofman, Michael
    Kong, Grace
    Thang, Sue-Ping
    Michael, Michael
    Hicks, Rodney J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Tumors (NETs): A United States Experience
    Katona, Bryson
    Riff, Brian
    Soulen, Michael
    Pryma, Daniel
    Bennett, Bonita
    Wild, Damian
    Nicolas, Guillaume
    Teitelbaum, Ursina
    Metz, David
    PANCREAS, 2017, 46 (03) : 439 - 439
  • [10] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues
    Bodei, L.
    Pepe, G.
    Paganelli, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (04) : 347 - 351
12345